Merck Animal Health launches NOBIVAC NXT Rabies vaccines

New rabies vaccine line for dogs and cats

Merck Animal Health has launched NOBIVAC NXT Rabies, a nonadjuvanted rabies vaccine line for dogs and cats, according to dvm360. The launch includes 1-year and 3-year formulations.

dvm360 reported that the products arrived weeks after the CDC warned of a nationwide increase in reported human rabies exposures. The publisher identified that warning as the public-health context for the Merck Animal Health announcement.

The launch puts a new companion-animal rabies vaccine product update before veterinary practices and the animal health professionals who support them. The reported product details center on its nonadjuvanted status, its dog and cat use, and the availability of two formulation durations.

Product details reported by dvm360

• NOBIVAC NXT Rabies is a rabies vaccine line from Merck Animal Health.
• The vaccines are nonadjuvanted.
• The line is for dogs and cats.
• Merck Animal Health launched 1-year and 3-year formulations.

For veterinary sales professionals, the announcement provides a defined product update for conversations with clinic teams. dvm360’s report supports discussion of the named vaccine line, the applicable companion-animal species, and the reported formulation options.

Rabies prevention context

dvm360 connected the launch with the CDC warning of increased reported human rabies exposures nationwide. That connection places the product announcement within a broader rabies-prevention discussion involving companion animals and veterinary care teams.

Clinic conversations around the launch can remain focused on the information reported by dvm360: Merck Animal Health’s NOBIVAC NXT Rabies line is nonadjuvanted, is intended for dogs and cats, and is available in 1-year and 3-year formulations. The CDC warning cited by dvm360 adds context to the timing of the announcement.

As veterinary teams review rabies vaccination workflows, the new line represents an additional Merck Animal Health product announcement in the companion-animal category. dvm360 reported the launch alongside the nationwide increase in reported human rabies exposures identified by the CDC.